To test this, we conducted combined experiments using DAC with radiotherapy, which demonstrated that DAC effectively reduced TFAP2C methylation levels, restored its expression, increased OTUD1 levels, and significantly enhanced radiosensitivity in NPC cells. Here, TFAP2C is linked to nasopharyngeal carcinoma.